Orion Corporation

📍 Espoo, Finland👥 1,984 employees💰 Last funded May 2020
Pharmaceutical Manufacturing🌐 orion.fi
Website LinkedIn
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are oncology and pain. Orion's net sales in 2022 amounted to EUR 1,341 million and the company had about 3,500 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki. Product related questions and feedback: www.orion.fi/en/contact-us/product-related-questions-and-feedback
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Finland
1
Frequently asked questions
Who invested in Orion Corporation?
Orion Corporation has 1 investors on record on gritt.io.
When did Orion Corporation last raise funding?
The most recent investment in Orion Corporation recorded on gritt.io was in May 2020.
What industry is Orion Corporation in?
Orion Corporation operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Orion Corporation based?
Orion Corporation is headquartered in Espoo, Finland.